Safety of COVID-19 vaccines in subjects with solid tumor cancers receiving immune checkpoint inhibitors-Reference-Cited by-同舟云学术

Safety of COVID-19 vaccines in subjects with solid tumor cancers receiving immune checkpoint inhibitors

Published:2023-01-02 Issue:1 Volume:19 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Gilbert Danielle¹,Hu Junxiao²,Medina Theresa¹,Kessler Elizabeth R.¹,Lam Elaine T.¹

Affiliation:

1. Department of Internal Medicine, Division of Medical Oncology, University of Colorado Cancer Center, University of Anschutz Medical Campus, Aurora, CO, USA

2. Department of Biostatistics, University of Colorado Cancer Center Biostatistics Core, University of Colorado Anschutz Medical Campus, Aurora, CO, USA

Funder

National Cancer Institute

the University of Colorado

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2023.2207438

Reference38 articles.

1. Impact of COVID-19 on Cancer Care: How the Pandemic Is Delaying Cancer Diagnosis and Treatment for American Seniors

2. Clinical Characteristics and Outcomes of COVID-19–Infected Cancer Patients: A Systematic Review and Meta-Analysis

3. Clinical Characteristics and Outcomes in Patients with COVID-19 and Cancer: a Systematic Review and Meta-analysis

4. The Advisory Committee on Immunization Practices’ Updated Interim Recommendation for Allocation of COVID-19 Vaccine — United States, December 2020

5. American Society of Clinical Oncology. COVID-19 vaccines & patients with cancer. 2021. www.asco.org/asco-coronavirus-information/covid-19-vaccines-patients-cancer.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. mRNA-1273 vaccination induces polyfunctional memory CD4 and CD8 T cell responses in patients with solid cancers undergoing immunotherapy or/and chemotherapy;Frontiers in Immunology;2024-08-27

3. Immune checkpoint inhibitors and SARS-CoV2 infection;International Immunopharmacology;2024-08

4. Vaccination of Adults With Cancer: ASCO Guideline;Journal of Clinical Oncology;2024-05-10

5. Serological response and immune‐related adverse events following COVID‐19 vaccination in cancer patients treated with immune checkpoint inhibitors: A systematic review and meta‐analysis;Reviews in Medical Virology;2023-11-28